Frequently Asked Questions
The market is segmented based on , By Medication (Lubricating Eye Drops, Vasoconstrictor, Analgesic & Pain Relief, Antiviral, Others), Product Type (Eye Drop, Eye Ointment, Liquid Wipes, Gel, Others), Route of Administration (Oral, Parenteral, Ocular, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
.
The Global Viral Conjunctivitis Market size was valued at USD 300.00 USD Million in 2021.
The Global Viral Conjunctivitis Market is projected to grow at a CAGR of 5% during the forecast period of 2022 to 2029.
The major players operating in the market include Bausch Health Companies , Merck & Co. , Pfizer , Teva Pharmaceutical Industries Ltd, Amorphex Therapeutics Holdings , Kubota Vision , Alcon Vision LLC, Astellas Pharma , Bayer AG, Novartis AG, Nidek Co Ltd, Mitotech SA.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
